Literature DB >> 31255129

Impact of hydrostatic pressure on phase-change contrast agent activation by pulsed ultrasound.

Saurabh Raut1, Mawia Khairalseed1, Arvin Honari1, Shashank R Sirsi1, Kenneth Hoyt1.   

Abstract

A phase-change contrast agent (PCCA) can be activated from a liquid (nanodroplet) state using pulsed ultrasound (US) energy to form a larger highly echogenic microbubble (MB). PCCA activation is dependent on the ambient pressure of the surrounding media, so any increase in hydrostatic pressure demands higher US energies to phase transition. In this paper, the authors explore this basic relationship as a potential direction for noninvasive pressure measurement and foundation of a unique technology the authors are developing termed tumor interstitial pressure estimation using ultrasound (TIPE-US). TIPE-US was developed using a programmable US research scanner. A custom scan sequence interleaved pulsed US transmissions for both PCCA activation and detection. An automated US pressure sweep was applied, and US images were acquired at each increment. Various hydrostatic pressures were applied to PCCA samples. Pressurized samples were imaged using the TIPE-US system. The activation threshold required to convert PCCA from the liquid to gaseous state was recorded for various US and PCCA conditions. Given the relationship between the hydrostatic pressure applied to the PCCA and US energy needed for activation, phase transition can be used as a surrogate of hydrostatic pressure. Consistent with theoretical predictions, the PCCA activation threshold was lowered with increasing sample temperature and by decreasing the frequency of US exposure, but it was not impacted by PCCA concentration.

Entities:  

Year:  2019        PMID: 31255129      PMCID: PMC6570615          DOI: 10.1121/1.5111345

Source DB:  PubMed          Journal:  J Acoust Soc Am        ISSN: 0001-4966            Impact factor:   1.840


  60 in total

1.  On the acoustic vaporization of micrometer-sized droplets.

Authors:  Oliver D Kripfgans; Mario L Fabiilli; Paul L Carson; J Brian Fowlkes
Journal:  J Acoust Soc Am       Date:  2004-07       Impact factor: 1.840

2.  In vivo pressure estimation using subharmonic contrast microbubble signals: proof of concept.

Authors:  Flemming Forsberg; Ji-Bin Liu; William T Shi; Junji Furuse; Masafumi Shimizu; Barry B Goldberg
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2005-04       Impact factor: 2.725

3.  Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications.

Authors:  Alphonse G Taghian; Rita Abi-Raad; Sherif I Assaad; Adrian Casty; Marek Ancukiewicz; Eren Yeh; Peryhan Molokhia; Khaled Attia; Timothy Sullivan; Irene Kuter; Yves Boucher; Simon N Powell
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

4.  Interstitial hypertension in head and neck tumors in patients: correlation with tumor size.

Authors:  R Gutmann; M Leunig; J Feyh; A E Goetz; K Messmer; E Kastenbauer; R K Jain
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

5.  Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements.

Authors:  M Milosevic; A Fyles; D Hedley; M Pintilie; W Levin; L Manchul; R Hill
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

6.  Oncotic pressure in solid tumors is elevated.

Authors:  M Stohrer; Y Boucher; M Stangassinger; R K Jain
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

Review 7.  High interstitial fluid pressure - an obstacle in cancer therapy.

Authors:  Carl-Henrik Heldin; Kristofer Rubin; Kristian Pietras; Arne Ostman
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

8.  Interstitial hypertension in human breast and colorectal tumors.

Authors:  J R Less; M C Posner; Y Boucher; D Borochovitz; N Wolmark; R K Jain
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

9.  Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.

Authors:  Kristian Pietras; Kristofer Rubin; Tobias Sjöblom; Elisabeth Buchdunger; Mats Sjöquist; Carl-Henrik Heldin; Arne Ostman
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

10.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

View more
  2 in total

1.  Polyvinyl Alcohol Cryogels for Acoustic Characterization of Phase-Change Contrast Agents.

Authors:  Phillip G Durham; Jinwook Kim; Katherine M Eltz; Charles F Caskey; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2022-03-01       Impact factor: 3.694

2.  Repeated Acoustic Vaporization of Perfluorohexane Nanodroplets for Contrast-Enhanced Ultrasound Imaging.

Authors:  Austin Van Namen; Sidhartha Jandhyala; Tomas Jordan; Geoffrey P Luke
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-11-23       Impact factor: 2.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.